HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuronal and glial proteins in medulloblastomas. I. Immunohistochemical study.

Abstract
Neuronal and glial specific proteins were studied in 35 cases of medulloblastomas, using immunohistochemical methods and antibodies to neurofilament triplet proteins (NF68Kd, NF160Kd, NF210Kd), gamma-enolase, GFAP, S-100 protein, and myelin basic protein. NF160Kd positive cells were observed in 12 of the 35 cases. NF160Kd positive cells were noted in 2, but NF210Kd positive cells were not detected. Gamma-enolase positive cells were observed in 23 cases. GFAP and S-100 protein positive cells were seen in 25 and 28 cases respectively; many of these cells were reactive astrocytes. The myelin basic protein positive cells could not be identified. The expression of neuronal and glial proteins had no relation to the postoperative survival of patients with medulloblastoma, but gamma-enolase may be one factor for evaluating prognosis.
AuthorsH Sawa, I Takeshita, M Kuramitsu, H Mannoji, T Machi, M Fukui, K Kitamura
JournalAnticancer research (Anticancer Res) 1986 Sep-Oct Vol. 6 Issue 5 Pg. 905-9 ISSN: 0250-7005 [Print] Greece
PMID2432834 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glial Fibrillary Acidic Protein
  • Intermediate Filament Proteins
  • Myelin Basic Protein
  • Neurofilament Proteins
  • S100 Proteins
  • Phosphopyruvate Hydratase
Topics
  • Adolescent
  • Adult
  • Cerebellar Neoplasms (analysis)
  • Child
  • Child, Preschool
  • Female
  • Glial Fibrillary Acidic Protein (analysis)
  • Histocytochemistry
  • Humans
  • Infant
  • Infant, Newborn
  • Intermediate Filament Proteins (analysis)
  • Male
  • Medulloblastoma (analysis)
  • Myelin Basic Protein (analysis)
  • Neurofilament Proteins
  • Phosphopyruvate Hydratase (analysis)
  • Prognosis
  • S100 Proteins (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: